CTx1000

· Celosia Therapeutics Pty Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CTx1000, covering 2026-02-10 to 2026-02-10. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability Study of CTx1000 In Participants With Amyotrophic Lateral Sclerosis [Phase 1]